Skip to main content
Smart Investors Daily
AI

NASDAQ · AIRS

AirSculpt Technologies, Inc.

Healthcare · Medical - Care Facilities

$1.20

Down-$0.02 (-1.67%)

Updated Oct 26, 2026, 3:50 PM

SID Score

2.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
98.65M
P/E ratio
-5.29
Dividend yield
0.00%
52-week range
$1.15 – $12.00
Volume
251.62K
Avg. volume
1.04M

Price performance · AIRS

AIRS price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 23, 2026

AIRS closed at $1.20 after 20 trading sessions, down 36.17% for the selected period.

Last close
$1.20
Period change
-36.17%
Period low
$1.20
Period high
$1.91
Daily close
View OHLC price history
AIRS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 23, 2026$1.25$1.25$1.19$1.20251.62K
Oct 22, 2026$1.265$1.275$1.15$1.251.31M
Oct 21, 2026$1.31$1.3599$1.25$1.28603.45K
Oct 20, 2026$1.26$1.35$1.21$1.30591.35K
Oct 19, 2026$1.31$1.31$1.155$1.2451.2M
Oct 16, 2026$1.43$1.43$1.24$1.2751.15M
Oct 15, 2026$1.43$1.44$1.38$1.415502.22K
Oct 14, 2026$1.59$1.5993$1.41$1.42809.08K
Oct 13, 2026$1.65$1.675$1.6001$1.62626.69K
Oct 12, 2026$1.60$1.70$1.586$1.63735.83K
Oct 9, 2026$1.65$1.685$1.59$1.621.02M
Oct 8, 2026$1.80$1.80$1.65$1.6551.11M
Oct 7, 2026$1.82$1.90$1.78$1.82877.92K
Oct 6, 2026$1.95$2.025$1.845$1.86724.57K
Oct 5, 2026$1.81$1.96$1.805$1.91832.38K
Oct 2, 2026$1.74$1.85$1.72$1.77886.66K
Oct 1, 2026$1.74$1.81$1.635$1.701.41M
Sep 30, 2026$1.84$1.85$1.68$1.761.13M
Sep 29, 2026$1.87$1.95$1.78$1.80731.34K
Sep 28, 2026$1.91$1.9604$1.8534$1.88788.46K

Latest AIRS news

The latest Smart Investors Daily articles mentioning AIRS.

AIRS research

Overview

Company profile and research snapshot.

Company profile

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.00
Implied upside
—
Analysts
—
AIRS recent ratings
DateFirmRatingTarget
Mar 31, 2025Leerink PartnersMarket Perform—
Jan 17, 2025Piper SandlerNeutral—
Jan 6, 2025Piper SandlerNeutral—
Oct 17, 2024BTIGNeutral—
May 14, 2024Leerink PartnersMarket Perform—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.